Clinical trial
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in…
NCT00488241 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00488241 |
|---|---|
| Title | Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema |
| Official title | A Multicenter, Open Uncontrolled Clinical Study to Examine the Efficacy and Safety of Zarzenda in the Management of Hand Eczema |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hand Eczema |
| Intervention type | Device |
| Interventions | Zarzenda |
| Enrollment | 40 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Oct 31, 2023 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: